bioMérieux Records 7.3% Organic Growth Over the First Nine Months of 2025
bioMérieux has announced a 7.3% increase in organic sales growth for the first nine months of the year, reaching 2,992 million euros, according to the press release.
Sales Performance and Market Dynamics
According to information provided by bioMérieux, consolidated sales for the first nine months of 2025 reached 2,992 million euros, representing a growth of 4.2% compared to the same period last year, where sales amounted to 2,871 million euros. This increase includes an organic growth of 7.3%, although the impact of currency effects was negative, representing a decrease of 85 million euros. In terms of quarterly performance, the company observed an organic sales growth of 3% in the third quarter, affected by a double-digit decline in China and an 8% drop in sales of BIOFIRE® respiratory panels, a segment influenced by low epidemiological activity.
Expansion of Product Portfolio and Installed Base
bioMérieux continues to expand its installed base, particularly for its BIOFIRE® and SPOTFIRE® systems, which have shown growths of 9% and 114% respectively over the first nine months. The company also obtained FDA 510(k) clearance and CLIA waiver for its SPOTFIRE® R/ST Panel Mini test, thereby enhancing its diagnostic offerings. Additionally, bioMérieux launched GENE-UP® PRO HRM, a new quality control solution based on DNA detection of thermoresistant molds. These actions are part of the strategic plan GO•28 aimed at continuous profitability improvement.
2025 Forecasts Adjusted
bioMérieux has adjusted its forecasts for 2025, expecting an organic revenue growth between 5.5% and 6.5% at constant exchange rates, thus revising its previous forecasts downward due to a late respiratory season. However, the company maintains its growth forecasts for current contributory operating income (ROCC), which is expected to increase between 12% and 18%, also at constant exchange rates. Nevertheless, currency effects are expected to negatively impact annual CEBIT by 30 million euros. In terms of regions, North America and Latin America show positive dynamics, while Asia-Pacific, particularly China, records performance declines.
